RESEARCH-USE BIOSIMILAR ANTIBODY

Galegenimab

Antibody fragment · IgG1

HTRA1IgG1RUO

Galegenimab (FHTR 2163) is a humanized monoclonal antibody Fab fragment targeting the HtrA1 trimer. Galegenimab is used in research on age-related macular degeneration (AMD).

TARGETHTRA1
YAntibody fragment
CATALOGSC-BS-521
CATALOG NUMBERSC-BS-521
MOLECULAR WEIGHTApprox. 47.71 kDa
PRODUCT FORMATAntibody fragment

A research-use configuration for comparative antibody studies

Galegenimab (FHTR 2163) is a humanized monoclonal antibody Fab fragment targeting the HtrA1 trimer. Galegenimab is used in research on age-related macular degeneration (AMD).

Galegenimab is a recombinant research-use antibody directed against HTRA1.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Galegenimab | StellaCyte